---
category: news
title: "GigaGen Publishes Research Demonstrating the Potential of its Machine Learning Platform to Improve Antibody Drug Discovery and Development"
excerpt: "GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immune deficiencies, infectious diseases and checkpoint resistant cancers, and a subsidiary of Grifols, announced today the publication of a research article titled,"
publishedDateTime: 2022-05-19T15:42:00Z
originalUrl: "https://apnews.com/press-release/globe-newswire/technology-politics-health-fb10c053e6b4726543d08058b8ef5065"
webUrl: "https://apnews.com/press-release/globe-newswire/technology-politics-health-fb10c053e6b4726543d08058b8ef5065"
type: article
quality: 5
heat: -1
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - Machine Learning
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "Alchemab Announces Publication of AntiBERTa, an Antibody-Specific Machine Learning Model with Multiple Applications"
    excerpt: "Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire-based patient stratification tools, today announced the publication of research demonstrating the potential of AntiBERTa (Antibody-specific Bi-directional Encoder Representation and Transformers),"
    publishedDateTime: 2022-05-19T11:02:00Z
    webUrl: "https://www.joplinglobe.com/region/national_business/alchemab-announces-publication-of-antiberta-an-antibody-specific-machine-learning-model-with-multiple-applications/article_da6f3650-aed7-5f65-9195-14ab79557d5c.html"
    type: article
    provider:
      name: Joplin Globe
      domain: joplinglobe.com
    quality: 17
    images:
      - url: "https://static.cnhionline.com/ksherman/images/rtj_ad.gif"
        width: 300
        height: 250
        isCached: true

secured: "inrraFYvNdUhXVN9qUeYwIv5fIXETsRovyu+nLTvlFUULa0tuD4z4nU/kNU9s9akWVg10C6y3mpJMTshz76xqipHWL8I4eBu70mpkY2XdaELxson3gz7HgWSSFNIUgzplbacEIgN/FSZtQoigzySg2W7oHYtZiDSLLMsrOWv1GVnjtOgI4TBc01uRMAClQTfRGszmqK0U4aipV9CbxUAjGzve5e29r+3zfrj2OrWRQNUG4jq7PK/Qwtd9yirsMudutwacSbVmsfey1T+O0jKZBbM+gYBT/559glLbBjHmmQMo27L70mYaSlks+YSKFLm1CKCoXpN9hI7CfNdNCN5MTfrjDXRsiqBI4MxOXB7JPw=;JtgHYdD9DYKXYByIRr5wyg=="
---

